SYN (Synapse) fluctuated 43.4% in 24 hours: Trading volume surged over 700%, driving organic rebound
Bitget Pulse2026/04/03 07:20Volatility Overview
In the past 24 hours, the price of SYN hit a low of $0.0463 and a high of $0.0664, with the current price at $0.0578. Overall amplitude was 43.4%, with a closing increase of approximately 21%-27%. 24-hour trading volume surged to about $24.8-26.8 million, up over 700%, and the Vol/Mkt Cap ratio reached 218%, indicating a significant improvement in liquidity.
Brief Analysis of the Unusual Movement Causes
• Main driver: Trading volume soared by more than 720% (jumping from the previous low of approximately $2-3 million), accompanied by an increase in organic buying pressure, with no clear project announcements or news catalysts.
• Secondary factor: No significant on-chain whale movements or large transaction reports, price movement is independent of the broader market (e.g., BTC only edged up by 0.05%).
Market Viewpoint and Outlook
Community sentiment is generally optimistic; technical analysis suggests a breakout from a descending wedge, with potential for further gains to $0.56. However, the RSI at 78 has entered the "euphoria zone," warning of a potential pullback risk. Analysts highlight concerns about thin liquidity and low revenue (daily average $11), cautioning that bulls should be wary of an overbought status in the short term.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.